4//SEC Filing
Hanna John Walter JR 4
Accession 0001437749-20-023003
CIK 0001384101other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:10 PM ET
Size
15.7 KB
Accession
0001437749-20-023003
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Hanna John Walter JR
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2020-11-05$9.05/sh+3,125$28,281→ 77,434 total - Exercise/Conversion
Common Stock
2020-11-05$5.98/sh+3,281$19,620→ 80,715 total - Sale
Common Stock
2020-11-05$40.00/sh−3,613$144,506→ 77,102 total - Sale
Common Stock
2020-11-05$41.56/sh−2,660$110,548→ 74,442 total - Sale
Common Stock
2020-11-05$42.08/sh−133$5,597→ 74,309 total - Exercise/Conversion
Stock Option (right to buy)
2020-11-05−3,125→ 7,292 totalExercise: $9.05Exp: 2027-03-02→ Common Stock (3,125 underlying) - Exercise/Conversion
Stock Option (right to buy)
2020-11-05−3,281→ 20,782 totalExercise: $5.98Exp: 2028-03-01→ Common Stock (3,281 underlying)
Footnotes (6)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $39.95 to $40.78. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F3]Represents weighted average sales price. Sale prices for the transactions range from $41.01 to $42.01. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F4]Represents weighted average sales price. Sale prices for the transactions range from $42.05 to $42.13. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F5]The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- [F6]The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
Documents
Issuer
VERACYTE, INC.
CIK 0001384101
Entity typeother
Related Parties
1- filerCIK 0001781127
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:10 PM ET
- Size
- 15.7 KB